title: Improved survival after brain metastases in non-seminomatous germ cell tumours with combined modality treatment.
abstract: Long-term disease-free survival (78 + and 31 + months) has been achieved in two of four patients treated for brain metastases from non-seminomatous germ cell tumours between 1980 and 1984. The incidence of cerebral metastases among 101 patients seen over the 5-year period was 4%. The encouraging results from the use of combined modality treatment, incorporating cisplatin-based chemotherapy, whole brain irradiation and surgery, are reviewed.
authors.affiliation: Urological Cancer Research Unit, Royal Prince Alfred Hospital, Camperdown, Australia.
authors.forename: D
authors.initials: D
authors.lastname: Raghavan
authors.forename: J F
authors.initials: JF
authors.lastname: Mackintosh
authors.forename: R M
authors.initials: RM
authors.lastname: Fox
authors.forename: J
authors.initials: J
authors.lastname: Rogers
authors.forename: P
authors.initials: P
authors.lastname: Duval
authors.forename: M
authors.initials: M
authors.lastname: Besser
mesh_terms: D000328:Adult; D001932:Brain Neoplasms / Q000401:mortality / Q000556:secondary* / Q000628:therapy; D002945:Cisplatin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000401:mortality / Q000556:secondary* / Q000628:therapy; D013736:Testicular Neoplasms / Q000401:mortality
chemical_list: D002945:Cisplatin